NR4A1 and breast cancer: To systematically investigate the functional significance of ARL3 in modulating proliferative capacity and endocrine therapeutic responsiveness in hormone receptor‐positive (HR+) breast malignancies, we established a syngeneic orthotopic transplantation model using HR+ breast cancer cells with stable ARL3 knockout (ARL3‐KO) or control (sgNC) expression.